Nifty needs to hold above 17400 for upside; buy Hindalco, Sun Pharma stocks, charts show strength By Rahul Shah Equity benchmark BSE Sensex plummeted nearly 500 points (1%) while the Nifty dived below the 17,400-level (down 142 points or 1%) against the previous week, tracking heavy selling in global equities after US consumer inflation soared to a 40-year high in January, raising the prospects of faster-than-expected rate hikes by the Federal Reserve and geo-political tension. A sharp fall in the rupee and unabated foreign fund outflows added to the pressure. Nifty information technology, realty, Banks, mid-cap, small cap and FMCG Index fell 1-2% while Nifty metal Index climbed up by 3% on account of increased base metal price on LME (Copper price 13-year high). Nifty Auto Index managed to end on a flat note against the previous week close. Of the five sessions, Sensex and Nifty advanced in three sessions and declined in two sessions, including Friday. FIIs were net sellers of nearly $1.5bn during the month of February. The volatility in the markets may continue on account of US-Russia geo-political tension. The U.S. warned Russia could take offensive military action against Ukraine as early as next week. Surging inflation and monetary policy tightening elsewhere, notably in the US and Europe, is making investors nervous. Brent crude rose to $95 a barrel for the first time since September 2014 is a concern in the domestic market. Continued FIIs selling and mixed bag of quarterly results may have a negative impact in the market. Among the global economy front, India, China, and the UK will release inflation figures. Minutes of the US FOMC meeting will also be out. With earnings season winding down, investors will turn their attention back to macroeconomic concerns, with special focus on inflation numbers. LIC is expected to bring its public issue at a valuation of around Rs 12 lakh crore to Rs 15 lakh crore, which would help the government raise enough funds to meet its Rs 78,000-crore divestment target for 2021-22 and may reduce fiscal deficit. For the Nifty 50 index, sustaining above 17400 is the key factor from a short-term perspective. If the market is unable to sustain the level of 17400, the market might see the correction till the level of 17100 while resistance is expected at 17600- 17780. Hindalco Industries CMP: Rs 542, Stop loss: Rs 525 Target: Rs 575 Hindalco has given a multi-year breakout and has been consistently forming higher highs – higher lows on the monthly scale. It is trading into the lifetime high territory and has formed a bullish candle on a weekly scale with substantial pick up in volumes. RSI oscillator is moving northward on a weekly and monthly scale and thus showing further strength in the counter. Considering current chart structure, we advise traders to buy the stock for an up move towards 575 with stop-loss of525 Sun Pharma CMP: Rs 880 , Stop loss: Rs 865 Target: Rs 920 Sun Pharma has given breakout on daily scale and retested the same. It has given a range breakout on higher degree frame as well which indicates overall strength in the counter. RSI oscillator is also positively placed on the daily and weekly scale. Considering the current chart structure, we advise traders to buy the stock for an up move towards 920 with a stop loss of 865 (Rahul Shah (Senior Vice President, Group Advisory Leader-PCG, Broking & Distribution at Motilal Oswal Financial Services). Views expressed are the author’s own.)
Also Read: Zerodha’s Nikhil Kamath tells when to buy stocks, shares Buffett formula to find the right time
FII and DII trades: Foreign Institutional Investors (FII) have been net buyers of domestic stocks for successive days now. On Wednesday, FIIs pumped in Rs 2,347 crore. Domestic Institutional Investors (DII) have been net sellers, pulling out Rs 510 crore yesterday.
IPO watch: Syrma SGS Technology enters the final day of bidding today. So far the issue, that opened last week, has been subscribed 2.27 times. Retail investors have subscribed their portion 2.66 times while NIIs have bid for their quota 3.58 times and QIB portion has been bid for 0.71 times.
Analysts at Hem Securities, however, had positive views with a 鈥楽ubscribe鈥 rating. 鈥淐ompany is bringing the issue at price band of Rs 310-326 per share at p/e multiple of 21x on 9 Months FY22 EPS basis. Company with international Accreditations and product approvals is specialized in production of Stainless-Steel Pipes and Tubes with multi-fold demand of its Products & Customer Diversification.Hence we recommend 鈥淪ubscribe鈥 on issue,鈥 Hem Securities had said earlier.